VSTM · NASDAQ
Verastem (VSTM) Stock Price & Fundamentals
Verastem (VSTM) closed at $321.55 on Oct 9, 2026, up 0.90% from the previous close of $318.67.
Share price, past year
1Y +38.27%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $321.55 |
| Sep 30, 2026 | $317.85 |
| Aug 31, 2026 | $301.90 |
| Jul 31, 2026 | $287.01 |
| Jun 30, 2026 | $309.40 |
| May 29, 2026 | $298.00 |
| Apr 30, 2026 | $283.72 |
| Mar 31, 2026 | $270.43 |
| Feb 27, 2026 | $263.91 |
| Jan 30, 2026 | $262.50 |
| Dec 31, 2025 | $267.27 |
| Nov 28, 2025 | $264.01 |
| Oct 31, 2025 | $247.95 |
Key statistics
- Market cap
- $29.09B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.25
- Revenue (TTM)
- —
- Net income (TTM)
- −$202.70M
- Shares outstanding
- 90.5M
- Dividend yield
- —
- 52-week range
- $232.26 – $323.47
Verastem's market cap is $29.09B, based on a share price of $321.55 and 90.5M shares outstanding as of Jun 30, 2026.
Financials
Verastem reported revenue of $30.91M for fiscal 2025, up 209.14% from fiscal 2024.
Verastem reported a net loss of $209.47M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $30.91M | +209.1% | −$209.47M | −677.6% | −$3.02 | — |
| FY2024ended Dec 31, 2024 | $10.00M | +285.2% | −$130.64M | −1,306.4% | −$3.66 | −$104.80M |
| FY2022ended Dec 31, 2022 | $2.60M | +26.5% | −$73.81M | −2,843.3% | −$4.57 | — |
| FY2021ended Dec 31, 2021 | $2.05M | −97.7% | −$71.20M | −3,468.1% | −$4.90 | −$53.70M |
| FY2020ended Dec 31, 2020 | $88.52M | +407.1% | −$67.73M | −76.5% | −$0.44 | −$33.54M |
| FY2019ended Dec 31, 2019 | $17.46M | −34.7% | −$149.21M | −854.8% | −$2.00 | −$138.53M |
| FY2018ended Dec 31, 2018 | $26.72M | — | −$72.43M | −271.1% | −$1.37 | −$76.02M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $40.08M | −$34.67M | −$0.35 |
| Q1 FY2026ended Mar 31, 2026 | $18.67M | −$36.59M | −$0.46 |
| Q3 FY2025ended Sep 30, 2025 | $11.24M | −$98.52M | −$1.35 |
| Q2 FY2025ended Jun 30, 2025 | $2.14M | −$25.93M | −$0.62 |
| Q2 FY2024ended Jun 30, 2024 | $10.00M | — | — |
| Q1 FY2022ended Mar 31, 2022 | $2.60M | — | — |
| Q4 FY2021ended Dec 31, 2021 | $545.00K | — | — |
| Q3 FY2021ended Sep 30, 2021 | $2.00K | — | — |
Company profile
- Name
- Verastem, Inc.
- Ticker
- VSTM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 117 Kendrick Street, Suite 500, Needham, MA 02494
- Incorporated in
- MA
- Fiscal year ends
- December
- SEC CIK
- 0001526119
Recent SEC filings
- Aug 7, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jun 23, 2026
- Jun 17, 2026
- May 26, 2026
- May 7, 2026
- May 7, 2026
Frequently asked questions
What is Verastem's stock price?
Verastem (VSTM) closed at $321.55 on Oct 9, 2026, up 0.90% from the previous close of $318.67.
What is Verastem's market cap?
Verastem's market cap is $29.09B, based on a share price of $321.55 and 90.5M shares outstanding as of Jun 30, 2026.
How much revenue does Verastem make?
Verastem reported revenue of $30.91M for fiscal 2025, up 209.14% from fiscal 2024.
Does Verastem pay a dividend?
Verastem's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Verastem, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures